Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics

Jean-Luc Fraikin's Biography



Jean-Luc Fraikin, CEO, Spectradyne

Dr Fraikin developed the initial MRPS technology during his PhD thesis work at UC Santa Barbara in Dr. Cleland's research group. He has worked in cancer cell biology and biochemistry, and at InDevR led prototyping efforts for a microfluidics-based molecular diagnostic platform. At Spectradyne, Dr Fraikin previously led the development of instrument fluidics, software, and system integration. He is now serving as Spectradyne's CEO.

Jean-Luc Fraikin Image

Accurate Concentration of Biological Nanoparticles – Why and How?

Thursday, 25 February 2021 at 13:30

Add to Calendar ▼2021-02-25 13:30:002021-02-25 14:30:00Europe/LondonAccurate Concentration of Biological Nanoparticles – Why and How?Extracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics in Virtual ConferenceVirtual ConferenceSELECTBIOenquiries@selectbiosciences.com

Extracellular vesicles (EVs), virus and non-viral drug delivery vehicles are rapidly moving from the research lab into real-world applications.  Why should we care about measuring the concentration of these biological nanoparticles accurately? In the case of a COVID vaccine for example, we should care because particle concentration is the dose!  In a broad range of applications, particle concentration is a critical parameter that must be carefully controlled in order to develop safe and effective products.  This talk will include a comparison of methods and examples to illustrate how accurate concentration measurements are important for good quality science.


Add to Calendar ▼2021-02-25 00:00:002021-02-26 00:00:00Europe/LondonExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and TherapeuticsExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics in Virtual ConferenceVirtual ConferenceSELECTBIOenquiries@selectbiosciences.com